InvestorsHub Logo
Followers 62
Posts 7549
Boards Moderated 1
Alias Born 01/02/2003

Re: north40000 post# 395359

Saturday, 12/10/2022 3:26:17 PM

Saturday, December 10, 2022 3:26:17 PM

Post# of 425926
Inflammatory disease in the brain is NOT the whole answer to Alzheimers Disease...but it may be lurking in the background, triggering the other factors that cause AD...I am optimistic that the Brave study, which will show whether slowing inflammation in the brain, by administering oral EPA in order to slow AD, will be successful.

Even though Brave is a small study, it is a thorough one and should it show a tendency for patients to be improved on Vascepa, IMO the FDA should approve this safe, relatively inexpensive drugs, with other larger confirmatory trials to be done afterwards.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News